Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Mar;72(3):487P–590P. doi: 10.1111/j.1476-5381.1981.tb11001.x

Proceedings of the British Pharmacological Society. 10th-12th September, 1980. Abstracts.

PMCID: PMC2071593  PMID: 7260488

Full text

PDF
487P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABRAHAMS V. C., HILTON S. M., ZBROZYNA A. Active muscle vasodilatation produced by stimulation of the brain stem: its significance in the defence reaction. J Physiol. 1960 Dec;154:491–513. doi: 10.1113/jphysiol.1960.sp006593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. AUKLAND K., BOWER B. F., BERLINER R. W. MEASUREMENT OF LOCAL BLOOD FLOW WITH HYDROGEN GAS. Circ Res. 1964 Feb;14:164–187. doi: 10.1161/01.res.14.2.164. [DOI] [PubMed] [Google Scholar]
  3. Adams R. N. Applications of modern electroanalytical techniques to pharmaceutical chemistry. J Pharm Sci. 1969 Oct;58(10):1171–1184. doi: 10.1002/jps.2600581002. [DOI] [PubMed] [Google Scholar]
  4. Alam M., Smirk F. H. Observations in man on a pulse-accelerating reflex from the voluntary muscles of the legs. J Physiol. 1938 Mar 14;92(2):167–177. doi: 10.1113/jphysiol.1938.sp003592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Amar-Costesec A., Wibo M., Thinès-Sempoux D., Beaufay H., Berthet J. Analytical study of microsomes and isolated subcellular membranes from rat liver. IV. Biochemical, physical, and morphological modifications of microsomal components induced by digitonin, EDTA, and pyrophosphate. J Cell Biol. 1974 Sep;62(3):717–745. doi: 10.1083/jcb.62.3.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Apperley E., Feniuk W., Humphrey P. P., Levy G. P. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol. 1980 Feb;68(2):215–224. doi: 10.1111/j.1476-5381.1980.tb10410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Arlock P., Gullberg B., Olsson S. R. Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine. Naunyn Schmiedebergs Arch Pharmacol. 1978 Aug;304(1):27–36. doi: 10.1007/BF00501374. [DOI] [PubMed] [Google Scholar]
  8. Armstrong-James M., Millar J. Carbon fibre microelectrodes. J Neurosci Methods. 1979 Oct;1(3):279–287. doi: 10.1016/0165-0270(79)90039-6. [DOI] [PubMed] [Google Scholar]
  9. Ashton D., Wauquier A. Behavioral analysis of the effects of 15 anticonvulsants in the amygdaloid kindled rat. Psychopharmacology (Berl) 1979 Sep;65(1):7–13. doi: 10.1007/BF00491971. [DOI] [PubMed] [Google Scholar]
  10. Babington R. G., Wedeking P. W. The pharmacology of seizures induced by sensitization with low intensity brain stimulation. Pharmacol Biochem Behav. 1973 Jul-Aug;1(4):461–467. doi: 10.1016/0091-3057(73)90013-0. [DOI] [PubMed] [Google Scholar]
  11. Beck C. H., Chambers W. W. Speed, accuracy, and strength of forelimb movement after unilateral pyramidotomy in rhesus monkeys. J Comp Physiol Psychol. 1970 Feb;70(2):1–22. doi: 10.1037/h0028698. [DOI] [PubMed] [Google Scholar]
  12. Benwell M. E., Balfour D. J. Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles. Psychopharmacology (Berl) 1979 May 8;63(1):7–11. doi: 10.1007/BF00426913. [DOI] [PubMed] [Google Scholar]
  13. Birch N. J., Goulding I. Lithium-nucleotide interactions investigated by gel filtration. Anal Biochem. 1975 May 26;66(1):293–297. doi: 10.1016/0003-2697(75)90750-2. [DOI] [PubMed] [Google Scholar]
  14. Blackburn T. P., Foster G. A., Greenwood D. T., Howe R. Effects of viloxazine, its optical isomers and its major metabolites on biogenic amine uptake mechanisms in vitro and in vivo. Eur J Pharmacol. 1978 Dec 1;52(3-4):367–374. doi: 10.1016/0014-2999(78)90291-1. [DOI] [PubMed] [Google Scholar]
  15. Blum K., Futterman S., Wallace J. E., Schwertner H. A. Naloxone-induced inhibition of ethanol dependence in mice. Nature. 1977 Jan 6;265(5589):49–51. doi: 10.1038/265049a0. [DOI] [PubMed] [Google Scholar]
  16. Borkowski K. R., Finch L. Cardiovascular responses to centrally administered adrenaline in spontaneous hypertensive rats [proceedings]. Br J Pharmacol. 1977 Sep;61(1):130P–130P. [PMC free article] [PubMed] [Google Scholar]
  17. Borkowski K. R., Finch L. Cardiovascular responses to intraventricular adrenaline in spontaneous hypertensive rats. Eur J Pharmacol. 1978 Feb 1;47(3):281–290. doi: 10.1016/0014-2999(78)90235-2. [DOI] [PubMed] [Google Scholar]
  18. Borland R. G., Nicholson A. N. Immediate effects on human performance of a 1,5-genzodiazepine (clobazam) compared with the 1,4-benzodiazepines, chlordiazepoxide hydrochloride and diazepam. Br J Clin Pharmacol. 1975 Jun;2(3):215–221. doi: 10.1111/j.1365-2125.1975.tb01578.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Brauer R. W., Mansfield W. M., Jr, Beaver R. W., Gillen H. W. Stages in development of high-pressure neurological syndrome in the mouse. J Appl Physiol Respir Environ Exerc Physiol. 1979 Apr;46(4):756–765. doi: 10.1152/jappl.1979.46.4.756. [DOI] [PubMed] [Google Scholar]
  20. Buckingham R. E., Hamilton T. C. Comparison of the anti-hypertensive response to beta-adrenoceptor blocking drugs in intact and adrenal-demedullated spontaneously hypertensive rats. Br J Pharmacol. 1980 Apr;68(4):667–676. doi: 10.1111/j.1476-5381.1980.tb10859.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Burnstock G. Autonomic neuroeffector junctions--reflex vasodilatation of the skin. J Invest Dermatol. 1977 Jul;69(1):47–57. doi: 10.1111/1523-1747.ep12497872. [DOI] [PubMed] [Google Scholar]
  22. Clough D. P., Conway J., Hatton R., Scott K. L. The effect of angiotensin converting enzyme inhibitor on baroreceptor reflexes in conscious dogs during sodium depletion [proceedings]. J Physiol. 1979 Oct;295:75P–76P. [PubMed] [Google Scholar]
  23. Colpaert F. C., Niemegeers C. J., Janssen P. A. On the ability of narcotic antagonists to produce the narcotic cue. J Pharmacol Exp Ther. 1976 Apr;197(1):180–187. [PubMed] [Google Scholar]
  24. Coppen A., Rama Rao V. A., Swade C., Wood K. Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action. Psychopharmacology (Berl) 1979 May 25;63(2):125–129. doi: 10.1007/BF00429689. [DOI] [PubMed] [Google Scholar]
  25. Coquil J. F., Goridis C., Mack G., Neff N. H. Monoamine oxidase in rat arteries: evidence for different forms and selective localization. Br J Pharmacol. 1973 Aug;48(4):590–599. doi: 10.1111/j.1476-5381.1973.tb08245.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Crossman A. R., Walker R. J., Woodruff G. N. Problems associated with iontophoretic studies in the caudate nucleus and substantia nigra. Neuropharmacology. 1974 Jun;13(6):547–552. doi: 10.1016/0028-3908(74)90144-0. [DOI] [PubMed] [Google Scholar]
  27. DAVIS R. T., MCDOWELL A. A., DETER C. W., STEELE J. P. Performance of rhesus monkeys on selected laboratory tasks presented before and after a large single dose of whole-body x radiation. J Comp Physiol Psychol. 1956 Feb;49(1):20–26. doi: 10.1037/h0047480. [DOI] [PubMed] [Google Scholar]
  28. DUFF F., PATTERSON G. C., SHEPHERD J. T. A quantitative study of the response to adenosine triphosphate of the blood vessels of the human hand and forearm. J Physiol. 1954 Sep 28;125(3):581–589. doi: 10.1113/jphysiol.1954.sp005182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Davies J., Dray A. Substance P in the substantia nigra. Brain Res. 1976 May 14;107(3):623–627. doi: 10.1016/0006-8993(76)90150-5. [DOI] [PubMed] [Google Scholar]
  30. De Mey J., Burnstock G., Vanhoutte P. M. Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP. Eur J Pharmacol. 1979 May 15;55(4):401–405. doi: 10.1016/0014-2999(79)90115-8. [DOI] [PubMed] [Google Scholar]
  31. Doba N., Reis D. J. Role of central and peripheral adrenergic mechanisms in neurogenic hypertension produced by brainstem lesions in rat. Circ Res. 1974 Mar;34(3):293–301. doi: 10.1161/01.res.34.3.293. [DOI] [PubMed] [Google Scholar]
  32. Dubocovich M. L., Langer S. Z. Dopamine and alpha adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors. J Pharmacol Exp Ther. 1980 Jan;212(1):144–152. [PubMed] [Google Scholar]
  33. ETTLINGER G., KALSBECK J. E. Changes in tactile discrimination and in visual reaching after successive and simultaneous bilateral posterior parietal ablations in the monkey. J Neurol Neurosurg Psychiatry. 1962 Aug;25:256–268. doi: 10.1136/jnnp.25.3.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Enero M. A., Langer S. Z. Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane. Naunyn Schmiedebergs Arch Pharmacol. 1975;289(2):179–203. doi: 10.1007/BF00501305. [DOI] [PubMed] [Google Scholar]
  35. Evans M. H. Potentiation of a cardioinhibitory reflex by hypothalamic stimulation in the rabbit. Brain Res. 1978 Oct 13;154(2):331–343. doi: 10.1016/0006-8993(78)90704-7. [DOI] [PubMed] [Google Scholar]
  36. Evans M. H. Stimulation of the rabbit hypothalamus: caudal projections to respiratory and cardiovascular centres. J Physiol. 1976 Aug;260(1):205–222. doi: 10.1113/jphysiol.1976.sp011511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. FASCIOLO J. C., ESPADA J., CARRETERO O. THE ESTIMATION OF BRADYKININOGEN CONTENT OF THE PLASMA. Acta Physiol Lat Am. 1963;13:215–220. [PubMed] [Google Scholar]
  38. Farjo I. B., Blackwood D. H. Reduction in tyrosine hydroxylase activity in the rat amygdala induced by kindling stimulation. Brain Res. 1978 Sep 22;153(2):423–426. doi: 10.1016/0006-8993(78)90427-4. [DOI] [PubMed] [Google Scholar]
  39. Finch L., Haeusler G., Thoenen H. Proceedings: Failure to induce experimental hypertension in rats after intraventricular injection of 6-hydroxydopamine. Br J Pharmacol. 1972 Feb;44(2):356P–357P. [PMC free article] [PubMed] [Google Scholar]
  40. Flavahan N. A., McGrath J. C. Blockage by yohimbine of prazosin-resistant pressor effects of adrenaline in the pithed rat. Br J Pharmacol. 1980 Jul;69(3):355–357. doi: 10.1111/j.1476-5381.1980.tb07021.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Fozard J. R., Ali A. T. Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1978 Jan-Feb;301(3):223–235. doi: 10.1007/BF00507041. [DOI] [PubMed] [Google Scholar]
  42. Fuller R. W., Clemens J. A., Kornfeld E. C., Snoddy H. D., Smalstig E. B., Bach N. J. Effects of (8beta)-8-[methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats. Life Sci. 1979 Jan 22;24(4):375–382. doi: 10.1016/0024-3205(79)90334-5. [DOI] [PubMed] [Google Scholar]
  43. GRAY E. G., WHITTAKER V. P. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat. 1962 Jan;96:79–88. [PMC free article] [PubMed] [Google Scholar]
  44. Gavras H., Brunner H. R., Turini G. A., Kershaw G. R., Tifft C. P., Cuttelod S., Gavras I., Vukovich R. A., McKinstry D. N. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N Engl J Med. 1978 May 4;298(18):991–995. doi: 10.1056/NEJM197805042981803. [DOI] [PubMed] [Google Scholar]
  45. Gavras H., Brunner H. R., Turini G. A., Kershaw G. R., Tifft C. P., Cuttelod S., Gavras I., Vukovich R. A., McKinstry D. N. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N Engl J Med. 1978 May 4;298(18):991–995. doi: 10.1056/NEJM197805042981803. [DOI] [PubMed] [Google Scholar]
  46. Ghysel-Burton J., Godfraind T. Stimulation and inhibition of the sodium pump by cardioactive steroids in relation to their binding sites and their inotropic effect on guinea-pig isolated atria. Br J Pharmacol. 1979 Jun;66(2):175–184. doi: 10.1111/j.1476-5381.1979.tb13662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Glowinski J., Iversen L. L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem. 1966 Aug;13(8):655–669. doi: 10.1111/j.1471-4159.1966.tb09873.x. [DOI] [PubMed] [Google Scholar]
  48. Goddard G. V., McIntyre D. C., Leech C. K. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol. 1969 Nov;25(3):295–330. doi: 10.1016/0014-4886(69)90128-9. [DOI] [PubMed] [Google Scholar]
  49. Godfraind T. Alternative mechanisms for the potentiation of the relaxation evoked by isoprenaline in aortae from young and aged rats. Eur J Pharmacol. 1979 Jan 15;53(3):273–279. doi: 10.1016/0014-2999(79)90133-x. [DOI] [PubMed] [Google Scholar]
  50. Godfraind T., De Pover A., Lutete D. N. Identification with potassium and vanadate of two classes of specific ouabain binding sites in a (Na+ + K+) ATPase preparation from the guinea-pig heart. Biochem Pharmacol. 1980 Apr 15;29(8):1195–1199. doi: 10.1016/0006-2952(80)90418-9. [DOI] [PubMed] [Google Scholar]
  51. Godfraind T., Ghysel-Burton J. The cardioactive properties of SC4453, a digoxin analogue with a C17 beta-pyridazine ring. Eur J Pharmacol. 1979 Dec 20;60(4):337–344. doi: 10.1016/0014-2999(79)90238-3. [DOI] [PubMed] [Google Scholar]
  52. Hardebo J. E., Edvinsson L., Owman C., Svendgaard N. A. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine. Neurology. 1978 Jan;28(1):64–70. doi: 10.1212/wnl.28.1.64. [DOI] [PubMed] [Google Scholar]
  53. Hervé D., Simon H., Blanc G., Lisoprawski A., Le Moal M., Glowinski J., Tassin J. P. Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat. Neurosci Lett. 1979 Dec;15(2-3):127–133. doi: 10.1016/0304-3940(79)96101-9. [DOI] [PubMed] [Google Scholar]
  54. Ichiyama A., Nakamura S., Nishizuka Y., Hayaishi O. Enzymic studies on the biosynthesis of serotonin in mammalian brain. J Biol Chem. 1970 Apr 10;245(7):1699–1709. [PubMed] [Google Scholar]
  55. Jenner P., Leigh N., Marsden C. D., Reavill C. Dopamine mediated circling behaviour is modulated by lesions of the ventromedial nucleus of the thalamus [proceedings]. Br J Pharmacol. 1979 Nov;67(3):432P–432P. [PMC free article] [PubMed] [Google Scholar]
  56. Kajda P. K., Birch N. J., O'Brien M. J., Hullin R. P. Rat-brain pyruvate kinase: purification and effects of lithium. J Inorg Biochem. 1979 Dec;11(4):361–366. doi: 10.1016/s0162-0134(00)80191-9. [DOI] [PubMed] [Google Scholar]
  57. Karobath M. Serotonin synthesis with rat brain synaptosomes. Effects of serotonin and monoamineoxidase inhibitors. Biochem Pharmacol. 1972 May 1;21(9):1253–1263. doi: 10.1016/0006-2952(72)90287-0. [DOI] [PubMed] [Google Scholar]
  58. Kelley A. E., Stinus L., Iversen S. D. Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones. Neurosci Lett. 1979 Mar;11(3):335–339. doi: 10.1016/0304-3940(79)90018-1. [DOI] [PubMed] [Google Scholar]
  59. Knight R. I., Smith I. R., Brimblecombe R. W. Separation and quantification of metabolites of radiolabelled histamine in brain [proceedings]. Br J Pharmacol. 1978 Nov;64(3):460P–460P. [PMC free article] [PubMed] [Google Scholar]
  60. Komiya Y., Kurokawa M. Asymmetry of protein transport in two branches of bifurcating axons. Brain Res. 1978 Jan 13;139(2):354–358. doi: 10.1016/0006-8993(78)90936-8. [DOI] [PubMed] [Google Scholar]
  61. Krueger B. K., Forn J., Walters J. R., Roth R. H., Greengard P. Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway. Mol Pharmacol. 1976 Jul;12(4):639–648. [PubMed] [Google Scholar]
  62. LEARY R. W., RUCH T. C. Activity, manipulation drive, and strength in monkeys subjected to low-level irradiation. J Comp Physiol Psychol. 1955 Aug;48(4):336–342. doi: 10.1037/h0048920. [DOI] [PubMed] [Google Scholar]
  63. Laduron P., Leysen J. Specific in vivo binding of neuroleptic drugs in rat brain. Biochem Pharmacol. 1977 May 15;26(10):1003–1007. doi: 10.1016/0006-2952(77)90486-5. [DOI] [PubMed] [Google Scholar]
  64. Leysen J. E., Gommeren W., Laduron P. M. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. Biochem Pharmacol. 1978 Feb 1;27(3):307–316. doi: 10.1016/0006-2952(78)90233-2. [DOI] [PubMed] [Google Scholar]
  65. Leysen J. E., Laduron P. M. Receptor binding properties in vitro and in vivo of some long-acting opiates. Arch Int Pharmacodyn Ther. 1978 Apr;232(2):243–246. [PubMed] [Google Scholar]
  66. MCCUBBIN J. W., KANEKO Y., PAGE I. H. Ability of serotonin and norepinephrine to mimic the central effects of reserpine on vasomotor activity. Circ Res. 1960 Jul;8:849–858. doi: 10.1161/01.res.8.4.849. [DOI] [PubMed] [Google Scholar]
  67. Masuda Y., Utsui Y., Shiraishi Y., Karasawa T., Yoshida K., Shimizu M. Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals. Epilepsia. 1979 Dec;20(6):623–633. doi: 10.1111/j.1528-1157.1979.tb04846.x. [DOI] [PubMed] [Google Scholar]
  68. Mildvan A. S. The role of metals in enzyme-catalyzed substitutions at each of the phosphorus atoms of ATP. Adv Enzymol Relat Areas Mol Biol. 1979;49:103–126. doi: 10.1002/9780470122945.ch3. [DOI] [PubMed] [Google Scholar]
  69. Niemegeers C. J., Janssen P. A. In vivo interaction of haloperidol and apomorphine. Arch Int Pharmacodyn Ther. 1978 Nov;236(1):43–50. [PubMed] [Google Scholar]
  70. Niemegeers C. J., Schellekens K. H., Van Bever W. F., Janssen P. A. Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs. Arzneimittelforschung. 1976;26(8):1551–1556. [PubMed] [Google Scholar]
  71. Nijkamp F. P., Van Den Bosch R., De Jong W. An opposing role for the adrenals in the hypotensive effects of propranolol in the spontaneously hypertensive rat. Eur J Pharmacol. 1979 Jun 15;56(3):187–195. doi: 10.1016/0014-2999(79)90171-7. [DOI] [PubMed] [Google Scholar]
  72. O'Brien M. J., Allin C. N., Birch N. J., Hullin R. P. Inhibition of rabbit muscle pyruvate kinase by lithium [proceedings]. Br J Pharmacol. 1977 Sep;61(1):121P–122P. [PMC free article] [PubMed] [Google Scholar]
  73. Pendleton R. G., Samler L., Kaiser C., Ridley P. T. Studies on renal dopamine receptors with a new agonist. Eur J Pharmacol. 1978 Sep 1;51(1):19–28. doi: 10.1016/0014-2999(78)90057-2. [DOI] [PubMed] [Google Scholar]
  74. Raabe W., Nicol S., Gumnit R. J., Goldberg N. D. Focal penicillin epilepsy increases cyclic GMP in cerebral cortex. Brain Res. 1978 Apr 7;144(1):185–188. doi: 10.1016/0006-8993(78)90448-1. [DOI] [PubMed] [Google Scholar]
  75. Racine R. J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281–294. doi: 10.1016/0013-4694(72)90177-0. [DOI] [PubMed] [Google Scholar]
  76. Racine R., Livingston K., Joaquin A. Effects of procaine hydrochloride, diazepam, and diphenylhydantoin on seizure development in cortical and subcortical structures in rats. Electroencephalogr Clin Neurophysiol. 1975 Apr;38(4):355–365. doi: 10.1016/0013-4694(75)90260-6. [DOI] [PubMed] [Google Scholar]
  77. Reavill C., Leigh N., Jenner P., Marsden C. D. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway. Exp Brain Res. 1979 Oct;37(2):309–316. doi: 10.1007/BF00237716. [DOI] [PubMed] [Google Scholar]
  78. Robin M. M., Palfreyman M. G., Zraika M. M., Schechter P. J. An analysis of the cortical and striatal involvement in dyskinesia induced in rats by intracerebral injection of GABA-transaminase inhibitors and picrotoxin. Eur J Pharmacol. 1980 Apr 4;62(4):319–327. doi: 10.1016/0014-2999(80)90099-0. [DOI] [PubMed] [Google Scholar]
  79. Saxena P. R. Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol. 1974 Jun;27(1):99–105. doi: 10.1016/0014-2999(74)90206-4. [DOI] [PubMed] [Google Scholar]
  80. Schwartz J. C. Histaminergic mechanisms in brain. Annu Rev Pharmacol Toxicol. 1977;17:325–339. doi: 10.1146/annurev.pa.17.040177.001545. [DOI] [PubMed] [Google Scholar]
  81. Scuvée-Moreau J. J., Dresse A. E. Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. Eur J Pharmacol. 1979 Aug 1;57(2-3):219–225. doi: 10.1016/0014-2999(79)90368-6. [DOI] [PubMed] [Google Scholar]
  82. Shannon H. E., Holtzman S. G. Evaluation of the discriminative effects of morphine in the rat. J Pharmacol Exp Ther. 1976 Jul;198(1):54–65. [PubMed] [Google Scholar]
  83. Starke K., Borowski E., Endo T. Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine. Eur J Pharmacol. 1975 Dec;34(2):385–388. doi: 10.1016/0014-2999(75)90268-x. [DOI] [PubMed] [Google Scholar]
  84. Starke K., Reimann W., Zumstein A., Hertting G. Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1978 Oct;305(1):27–36. doi: 10.1007/BF00497003. [DOI] [PubMed] [Google Scholar]
  85. Stoner H. B., Marshall H. W. The effect of trauma on the formaldehyde-induced fluorescence of noradrenaline in the hypothalamus and brain stem of the rat. Brain Res. 1975 Oct 24;97(1):1–15. doi: 10.1016/0006-8993(75)90910-5. [DOI] [PubMed] [Google Scholar]
  86. Struyker Boudier H. A., Bekers A. D. Adrenaline-induced cardiovascular changes after intrahypothalamic administration to rats. Eur J Pharmacol. 1975 Mar;31(1):153–155. doi: 10.1016/0014-2999(75)90088-6. [DOI] [PubMed] [Google Scholar]
  87. Tarsy D., Pycock C. J., Meldrum B. S., Marsden C. D. Focal contralateral myoclonus produced by inhibition of GABA action in the caudate nucleus of rats. Brain. 1978 Mar;101(1):143–162. doi: 10.1093/brain/101.1.143. [DOI] [PubMed] [Google Scholar]
  88. Taube H. D., Starke K., Borowski E. Presynaptic receptor systems on the noradrenergic neurones of rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1977 Sep;299(2):123–141. doi: 10.1007/BF00498554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Timmermans P. B., Kwa H. Y., van Zwieten P. A. Possible subdivision of postsynaptic alpha-adrenoceptors mediating pressor responses in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):189–193. doi: 10.1007/BF00500284. [DOI] [PubMed] [Google Scholar]
  90. Turnbull M. J., Watkins J. W. Change in sensitivity to halothane in the rat following administration of sodium barbitone in the drinking water [proceedings]. Br J Pharmacol. 1976 Oct;58(2):285P–286P. [PMC free article] [PubMed] [Google Scholar]
  91. Turnbull M. J., Watkins J. W. Determination of halothane-induced sleeping time in the rat: effect of prior administration of centrally active drugs. Br J Pharmacol. 1976 Sep;58(1):27–35. doi: 10.1111/j.1476-5381.1976.tb07689.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. VANE J. R. THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD. Br J Pharmacol Chemother. 1964 Oct;23:360–373. doi: 10.1111/j.1476-5381.1964.tb01592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Van Nueten J. M., Van Beek J., Janssen P. A. The vascular effects of flunarizine as compared with those of other clinically used vasoactive substances. Arzneimittelforschung. 1978;28(11):2082–2087. [PubMed] [Google Scholar]
  94. Virus R. M., Gebhart G. F. Pharmacologic actions of capsaicin: apparent involvement of substance P and serotonin. Life Sci. 1979 Oct 8;25(15):1273–1283. doi: 10.1016/0024-3205(79)90392-8. [DOI] [PubMed] [Google Scholar]
  95. Wada J. A., Osawa T., Sato M., Wake A., Corcoran M. E., Troupin A. S. Acute anticonvulsant effects of diphenylhydantoin, phenobarbital, and carbamazepine: a combined electroclinical and serum level study in amygdaloid kindled cats and baboons. Epilepsia. 1976 Mar;17(1):77–88. doi: 10.1111/j.1528-1157.1976.tb03386.x. [DOI] [PubMed] [Google Scholar]
  96. Wada J. A. Pharmacological prophylaxis in the kindling model of epilepsy. Arch Neurol. 1977 Jul;34(7):389–395. doi: 10.1001/archneur.1977.00500190023003. [DOI] [PubMed] [Google Scholar]
  97. Weitzell R., Tanaka T., Starke K. Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1979 Aug;308(2):127–136. doi: 10.1007/BF00499054. [DOI] [PubMed] [Google Scholar]
  98. Williams E. M. Electrophysiological basis for a rational approach to antidysrhythmic drug therapy. Adv Drug Res. 1974;9:69–101. [PubMed] [Google Scholar]
  99. Yaksh T. L., Farb D. H., Leeman S. E., Jessell T. M. Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science. 1979 Oct 26;206(4417):481–483. doi: 10.1126/science.228392. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES